A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers

A Phase I Trial of HDFL48(Weekly 48-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin) in Recurrent or Metastatic Colorectal Cancers

NCT00155558•National Taiwan University Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Recurrent or Metastatic Colorectal Cancer

Interventions

5-Fluorouracil, Leucovorin

Locations

Taiwan

Locations (1)

Department of Oncology, National Taiwan University hospital

Taipei, Taiwan

Key Dates

Start Date

March 1, 2001

Completion Date

December 1, 2005

Last Updated

July 25, 2007

Sponsors

Lead Sponsor

National Taiwan University Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 25, 2007Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions